View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Renewal of Novo Nordisk Pharmaceuticals’ cGMP certificate

The Danish Medicines Agency has recently renewed its cGMP certificate in accordance with EU GMP Part II (ICH Q7) for an additional three-year period.

Novo Nordisk Pharmaceuticals is the world-leading manufacturer of quaternary ammonium compounds.

Our cGMP manufactured pharmaceutical grade products, such as Benzalkonium Chloride, Cetrimide, Strong Cetrimide, MKC and CTAB, are in full compliance with ICH’s guide Q7 for API and are analysed according to Ph.Eur., BP, USP/NF and JP. We also offer access to CEP and DMF.

Visit our team of experts at CphI 2013 in Frankfurt at stand 62B48 in Hall 6.2 to discuss your specific requirements.

For more than 30 years, the National Research Council of Canada has been helping clients develop, optimise, scale-up and transfer bioprocesses to produce biologics and...
The Chinese hamster ovary (CHO) cell line is widely used for the production of recombinant proteins due to its high growth capacity and productivity, as...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology